glp 1 for multiple sclerosis Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety GLP-1 Targets MS Progression, ㅤ,

Compared with normal hepatic function, the estimated ratio of the mean AUC 0 was 0.99 (0.891.11) in mild impairment, 1.01 (0.911.12) in moderate impairment and 1.11 (0.961.30) in severe impairment

Common GLP-1 agonists include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Zepbound) While initially used for diabetes management, studies showed that GLP-1 agonists also contribute significantly to weight loss, leading to their approval for obesity treatment as well

NAC is valued primarily for its role in antioxidant production

03 Antioxidant Defense (Neutralizing Radicals) : Copper ions activate SOD and catalase, reducing oxidative stress and preventing structural protein degradation